"One recent small open label study observed a synergistic effect from a combination of hydroxychloroquine and azith at clearing viral load in the first week.6 Nevertheless, in a statement on 3 April, International Society of Antimicrobial Chemotherapy, expressed concerns that the article did not “meet the Society’s expected standard, especially relating to the lack of better explanation of the inclusion criteria and the triage of patients to ensure safety”.7
ref 6 is Gaudret - he might have excluded dead people
and the Brazil study
"The primary outcome was a reduction in lethality (that is, death) by at least 50% in the higher dose group and was due to be assessed after 28 days. The study had intended to enrol 440 patients but had only recruited 81 (41 to the higher dose, 40 the lower dose) before the data safety monitoring board terminated the trial. After 13 days, 39% (16/41) patients in the high dose group died compared with 15% (6/40) in the low dose group. The high dose group also experienced more instances of QTc prolongation (18.9% vs 11.1%). Overall, the risk of death was 3.6 times higher in the high dose group, a result that was statistically significant." (and led the trials abandonment}
long technical post - sozza funsters ! - but posted to refute the idea of 'we dont really know what the answer is' [poster looks wistful and puzzled]
It is obvious to me: chloroquine kills more than it cures